Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

FED × Breast Neoplasms × sargramostim × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER 19 NIH 8 INDUSTRY 2 FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2 Gynecologic 1

Conditions

Ovarian Neoplasms 2 Breast Neoplasms, Male 2 Breast Neoplasms 2 Endometrial Neoplasms 1

Interventions

sargramostim 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Exercise 1 Dexmedetomidine 1 Control Groups 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00524277 2020-03-30

Vaccine Therapy in Treating Patients With Breast Cancer

San Antonio Military Medical Center

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT02019524 2020-03-18

J65

San Antonio Military Medical Center

Phase 1 Completed

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡